TY - JOUR
T1 - Role of lactosylceramide and MAP kinase in the proliferation of proximal tubular cells in human polycystic kidney disease
AU - Chatterjee, Subroto
AU - Shi, Wan Y.
AU - Wilson, Patricia
AU - Mazumdar, Avi
N1 - Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 1996/6
Y1 - 1996/6
N2 - Polycystic kidney disease (PKD) is a common genetic disease characterized by the proliferation of epithelial cells, formation of cysts, and the progression of renal deficiency. We have investigated a possible role of glycosphingolipids in the proliferation of human kidney cells in this disease. The levels of glucosylceramide and lactosylceramide and the activity of glucosylceramide synthase (GlcT-1) and lactosylceramide synthase (GAlT-2) were elevated 2-fold and 3-fold, respectively, in the PKD tissue compared to control. Lactosylceramide, but not glucosylceramide (10 μM) derived from PKD exerted a 4-fold stimulation in the proliferation of these cells. However, at a concentration of 40 μM, lactosylceramide and glucosylceramide both stimulated cell proliferation on the order of 10-fold and 2.5-fold, respectively, as compared to control. This phenomenon may be due to the enrichment of lactosylceramide containing shorter chain tarry acids (C16:0- C18:0). Lactosylceramide, but not glucosyl-ceramide exerted a time-dependent stimulation in the phosphorylation of mitogen-activated protein kinase (p44 MAPK) in normal human kidney proximal tubular cells. Moreover, the kidneys and cultured cells from the PKD patients contained higher levels of the p44 MAPK as compared to normal human kidneys. In sum, our studies indicate that lactosyl-ceramide present in the PKD kidney may stimulate cell proliteration via activation of the p44 MAPK, and contribute to the pathophysiology in this disease.
AB - Polycystic kidney disease (PKD) is a common genetic disease characterized by the proliferation of epithelial cells, formation of cysts, and the progression of renal deficiency. We have investigated a possible role of glycosphingolipids in the proliferation of human kidney cells in this disease. The levels of glucosylceramide and lactosylceramide and the activity of glucosylceramide synthase (GlcT-1) and lactosylceramide synthase (GAlT-2) were elevated 2-fold and 3-fold, respectively, in the PKD tissue compared to control. Lactosylceramide, but not glucosylceramide (10 μM) derived from PKD exerted a 4-fold stimulation in the proliferation of these cells. However, at a concentration of 40 μM, lactosylceramide and glucosylceramide both stimulated cell proliferation on the order of 10-fold and 2.5-fold, respectively, as compared to control. This phenomenon may be due to the enrichment of lactosylceramide containing shorter chain tarry acids (C16:0- C18:0). Lactosylceramide, but not glucosyl-ceramide exerted a time-dependent stimulation in the phosphorylation of mitogen-activated protein kinase (p44 MAPK) in normal human kidney proximal tubular cells. Moreover, the kidneys and cultured cells from the PKD patients contained higher levels of the p44 MAPK as compared to normal human kidneys. In sum, our studies indicate that lactosyl-ceramide present in the PKD kidney may stimulate cell proliteration via activation of the p44 MAPK, and contribute to the pathophysiology in this disease.
KW - cpk mice
KW - gas chromatography-mass spectrometry
KW - lactosylceramide biosynthesis
KW - tyrosine kinase
UR - http://www.scopus.com/inward/record.url?scp=0029952346&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029952346&partnerID=8YFLogxK
M3 - Article
C2 - 8808768
AN - SCOPUS:0029952346
SN - 0022-2275
VL - 37
SP - 1334
EP - 1344
JO - Journal of Lipid Research
JF - Journal of Lipid Research
IS - 6
ER -